InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Kuhn Thomas, 首席执行官. Insider active across 1 company, notably POXEL. In total, 5 disclosures have been logged. Breakdown: 2 buys · 0 sell. History available since 24 August 2022. The latest transaction was filed on 29 January 2024 (Acquisition). Regulator: AMF. All data is free.
Companies and markets linked to Kuhn Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
80,000 股0ActionEuronext ParisISIN FR00124325162024DD948921
标准退出：2024年4月28日 (T+90)
150,000 股0ActionEuronext ParisISIN FR00124325162023DD894028
80,000 股0ActionEuronext ParisISIN FR00124325162023DD882619
标准退出：2023年4月27日 (T+90)
400,000 股0ActionHors plateforme de négociationISIN FR00124325162022DD877946
150,000 股0ActionHors plateforme de négociationISIN FR00124325162022DD858234
5 条申报中的 5 条
About Kuhn Thomas
Kuhn Thomas is the Chief Executive Officer of Poxel. He leads the company, which specializes in developing treatments for metabolic diseases. His role is crucial for the strategy and growth of Poxel in the pharmaceutical market.
